Medios AG starts the 2021 financial year with a record quarter 11.05.2021 / 07:21 Press Release Group sales and earnings nearly doubled in Q1 2021 First-time consolidation of Cranach Pharma GmbH Outlook 2021: Almost doubling of group sales and significant increase in earnings Berlin, 11 May 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, confirms its forecast for the 2021 financial year after a successful first quarter. Group sales in the period from January to March 2021 increased by 94.0% to ?315.9 million compared to the same period of the previous year (?162.8 million). EBITDA pre 1 increased by 106.5% to ?8.8 million (previous year ?4.3 million). EBT pre 1 climbed by 90.7% to ?7.1 million (previous year ?3.7 million). Thus, both group sales and earnings reached new record levels. Both operating segments contributed to the growth in group sales as well as earnings with improved operating margins.